PEGylated Magnetic Liposomes

PEGylated magnetic liposomes are sophisticated nanocarriers composed of lipid bilayers that encapsulate therapeutic agents while incorporating magnetic nanoparticles, such as iron oxide, for enhanced targeting capabilities. The addition of polyethylene glycol (PEG) on the liposomal surface improves biocompatibility, increases circulation time in the bloodstream, and reduces immunogenicity. These liposomes typically range from 100 to 200 nanometers in diameter, enabling efficient drug delivery to specific tissues, particularly in cancer therapy. The magnetic properties allow for targeted delivery and controlled release of encapsulated drugs when subjected to an external magnetic field, enhancing therapeutic efficacy while minimizing side effects. Additionally, the use of PEG helps stabilize the liposomes in biological environments, addressing issues of drug leakage and aggregation. Overall, PEGylated magnetic liposomes represent a promising approach in nanomedicine, combining the advantages of targeted therapy with improved pharmacokinetics for various biomedical applications.

MSDS of PEGylated Magnetic Liposomes